Oral GLP-1 Pills vs. Injections: Which One Is Right for You?

DESCRIPTION

For people who don't want to inject themselves, a daily GLP-1 pill sounds like the perfect answer. Rick and Greg look at oral Wegovy side by side with the weekly injection: the strict morning routine the pill needs, why so much of it is broken down in the stomach, and how close the weight loss results actually are.

They also bust the idea that the pill has fewer side effects, share a patient who used it to get comfortable before switching to the shot, and get on a soapbox about what happens when people stop. A GLP-1 is a tool, not a finish line, and the lifestyle changes you build while you're on it are what carry the results forward.

In this episode:
- Oral versus injectable semaglutide: routine, results, and side effects
- Using the pill as a way to test how you tolerate a GLP-1
- Weight regain, long-term use, and dropping the stigma
- Savings programs and what to check before you sign up

This episode is for educational and informational purposes only. Please see your own medical provider before starting or changing any medication or weight loss regimen.

Stay healthier ever after.

A patient switches her weekly GLP-1 injection from her abdomen to her arm in the middle of a frustrating plateau, and within days the scale starts moving again. She is convinced the site made the difference. Rick and Greg hear this story often in clinic, and in this episode they walk through what is actually happening physiologically versus what is more likely coincidence.

In this episode, Rick Sorensen, MD and Greg Camp, FNP break down:

• Why the abdomen, thigh, and upper arm are the three approved subcutaneous sites for semaglutide and tirzepatide (Ozempic, Wegovi, Mounjaro, Zepbound, and compounded versions)
• What the FDA label and manufacturer data actually show about drug exposure and absorption across those three sites
• Why so many people are convinced one site works better, and what plateaus and correlation versus causation have to do with it
• The decades-old insulin teaching that still shapes injection habits today, and why it does not carry over to a once-weekly GLP-1
• How to rotate within a site to avoid lipohypertrophy (that lumpy, thickened tissue) without needing to switch body parts entirely
• Injection etiquette that applies to any subcutaneous shot: clean skin, letting the alcohol dry, avoiding visible blood vessels, never reusing needles, and keeping insulin and GLP-1 injections separated
• A cautionary (and pretty funny) story about patients who spent over a month injecting air without realizing it

This episode is for education and information only. Please talk with your medical provider or pharmacist before starting, changing, or stopping any medication, weight loss program, or exercise routine, and ask for a hands-on demonstration of your injection technique if you have any questions at all.

Next up, we are tackling oral GLP-1s for anyone who would rather skip the needle altogether. Follow the show so you do not miss it, and stick around, because we have some exciting news about the Healthier Ever After brand coming very soon. If this episode helped, a quick rating or review helps other people trying to figure this out find the show.

Keywords:

GLP-1, semaglutide, tirzepatide, Ozempic, Wegovy, Mounjaro, Zepbound, GLP-1 injection sites, subcutaneous injection, weight loss injection, injection technique, lipohypertrophy, weight loss plateau, insulin vs GLP-1, GLP-1 side effects, metabolic health, weight loss medication, Healthier Ever After podcast

Self-criticism feels like it should motivate change, but the research says the opposite. In this episode, Rick and Greg cover a 2024 analysis linking self-criticism to disordered eating, and self-compassion to lower rates of it, then walk through what that looks like in real life: the shame spiral of "I ate three cookies, I've ruined everything," why cortisol from that kind of self-talk actually promotes fat storage, and how treating yourself the way you would treat a good friend who slipped up changes the outcome.

They also cover the flip side, kindness to others. Studies show volunteering and pro-social behavior in older adults are linked to lower inflammation, faster wound healing, and a 20 to 24 percent lower mortality risk, along with the oxytocin and endorphin boost that comes from being kind. They close with a caution on social media: constant exposure to weight loss and fitness content can drive body dysmorphia even in people who have made real progress, and a short break from it has been shown to improve body image.

Not medical advice. Consult your physician before starting any weight loss program, diet regimen, medication, or supplement.

Water is easy to overlook in a weight loss conversation, but it's involved in nearly every chemical reaction your body runs, including the ones that break down fat. In this episode, Rick and Greg explain the actual chemistry: why fat breakdown requires water, why most of the fat you lose leaves through your lungs as carbon dioxide, and why dehydration is one of the most common (and most overlooked) causes of hunger, headaches, and abdominal pain.

They also cover how to tell if you're dehydrated, why daily scale fluctuations are usually water weight and not fat, and three practical habits that make hydration easier: swapping sugary drinks for water, drinking 17 ounces before meals, and staying ahead of fluids if you're on a GLP-1 medication. They close with daily water targets, roughly 125 ounces for men and 91 ounces for women, adjusted for heat, altitude, illness, and activity level.

Not medical advice. Consult your physician before starting any weight loss program, diet regimen, medication, or supplement.

Peptides are all over the internet right now, and the headline is everywhere: the government voted, so they must be legal. In this episode, Rick Sorensen and Greg Camp separate what actually happened from what is being sold to you.

When the FDA's Pharmacy Compounding Advisory Committee met this past July to consider seven peptides, the agency's own scientists had already recommended rejecting every one of them. The panel voted the other way six times in a row, on a committee that had been reconstituted just weeks earlier. Rick and Greg explain what that vote really means, why nothing has legally changed, and why the approval road ahead is still one to two years long at best. They also look hard at the science behind popular peptides like BPC-157, and at what forensic testing has found inside products bought from unregulated sources.

In this episode:

• What the July FDA committee vote actually did, and why peptides are still not legal to compound
• A plain-English explanation of what peptides are and how compounding approval works
• Why the FDA's own scientists recommended no on all seven
• What the human evidence behind BPC-157 really shows
• What forensic testing found in seized, unregulated peptides
• What this means for patients, prescribers, and athletes

If peptides are on your radar, this is a practical, science-first, judgment-free guide to where things really stand.

Disclaimer: This podcast is for educational and informational purposes only and is not medical advice. We are not your medical provider. Always consult your own licensed medical provider before starting or changing any medication, supplement, or weight-loss plan.

Most of the frightening GLP-1 stories come down to one thing: the dose. In this episode, Rick Sorensen and Greg Camp explain why semaglutide and tirzepatide drive thousands of poison control calls and ER visits every year, and why almost all of them are preventable.

They dig into why injecting a medication is a completely different skill than swallowing a pill, how proper titration works (starting around a tenth of a full dose and building up over four to six months), and why the same dose can be a different number of units depending on the pharmacy and concentration you use. They also share a memorable story about a physician colleague who double-dosed by simply misreading a label, proof that this can happen to anyone.

In this episode:

• Why most GLP-1 “side effect” horror stories are really dosing errors
• The compounded-vial trap, and why the label on a big vial can mislead you
• Milligrams vs. units, and why you should ask for a hands-on demonstration
• Your pharmacist as an underused safety check before you inject
• What happens when you switch medications or pharmacies
• Microdosing, half-lives, and why people respond so differently

If you or someone you love is using a GLP-1 medication, this is a practical, judgment-free guide to using it safely.

Disclaimer: This podcast is for educational and informational purposes only and is not medical advice. We are not your medical provider. Always consult your own licensed medical provider before starting or changing any medication or weight-loss plan.

Rick opens this one with an image he couldn't shake after a trip to Denmark: you could take a two-ton block of marble and hammer 25% of the weight off it, and you'd still have a block. It looks like nothing. That, he argues, is what crash dieting does — and the actual goal is to pick away gently and intentionally at what you don't want while keeping the form that's already inside the stone.

From there, Rick and Greg build out the one-key, two-key, three-key model of GLP-1 medications. Every one of these drugs is a copycat key that fits a lock your body already has. Semaglutide turns one key, opening receptors in the brain that quiet food noise, in the stomach that slow gastric emptying, and in the pancreas that time insulin release to actual glucose spikes — with the tradeoff being nausea and GI side effects. Tirzepatide turns two, adding the GIP lock that calms the brain's nausea center and helps fat cells store fat where it belongs instead of tucking it into the liver and muscles, like dirty socks stuffed under the couch cushions. And retatrutide — still in trials, not approved, and the subject of some candid commentary here about Eli Lilly's biologic-classification maneuvering — turns three, adding glucagon to burn liver fat and nudge resting metabolic rate upward.

The numbers tell the arc: roughly 15% body weight on semaglutide, 21% on tirzepatide, and 28–30% in early retatrutide trials. But Rick and Greg keep circling back to the marble. Losing a hundred pounds the right way isn't chipping the block. It's chiseling the Michelangelo.

Educational and informational only. GLP-1 medications require a prescription and medical supervision. Retatrutide is not FDA approved and is not legally available. Talk with your healthcare provider before starting any medication, supplement, or weight loss program.

Cortisol has become the internet's favorite villain — but ask most people what it actually does and the answer is a shrug. Rick and Greg spend this episode fixing that, starting with the uncomfortable truth that you'd be very, very sick without it.

The key insight is that cortisol works on a schedule, not a setting. It spikes sharply in the morning to pull you out of sleep, declines through the day, and bottoms out around midnight. Chronic stress and poor sleep don't make that curve taller or shorter — they flatten it. And a flat curve means no pep in the morning, too much alertness at bedtime, and a cycle that feeds itself until one rough week has quietly become six months. Along the way, cortisol drives belly fat storage (that midsection has extra cortisol receptors), pushes you toward cravings for fast sugar rather than actual hunger, and taps your muscle protein as backup fuel.

Then comes the myth-busting: "cortisol face" isn't a medical term, adrenal fatigue and adrenal burnout aren't recognized diagnoses, a cortisol lab test is clinically close to meaningless unless you're screening for a specific disease like Addison's, and "adaptogen" is a marketing word rather than a pharmacological one. Rick calls what's left the boring list, and he's not wrong — sleep seven to nine hours on a consistent schedule, exercise you can actually recover from, morning daylight and dim light at night, eat enough on a regular schedule, breathe, spend time with people you like, and cut caffeine off eight to ten hours before bed. Unglamorous, free, and more effective than anything on the supplement shelf.

Greg's closing line says it best: cortisol isn't the enemy. Dysregulation is.

Educational and informational only. Talk with your healthcare provider before starting any supplement, exercise regimen, or weight loss program — and especially if you're dealing with persistent insomnia.